Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLP - 1”

356 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 356 results

Not applicableStudy completedNCT02235584
What this trial is testing

Insulinotropic Effect of GLP-1 and GIP After Dexamethasone

Who this might be right for
Type 2 Diabetes
Hvidovre University Hospital 19
Not applicableStudy completedNCT01656057
What this trial is testing

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Who this might be right for
To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion
Filip Krag Knop 10
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Post-approval studies (Phase 4)Not Yet RecruitingNCT07100691
What this trial is testing

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Who this might be right for
Pulmonary Aspiration During Anaesthetic InductionGastric Emptying TimePreoperative Risk Assessment+1 more
Mater Misericordiae University Hospital 80
Not applicableStudy completedNCT00716170
What this trial is testing

GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

Who this might be right for
Type 2 Diabetes Mellitus
Herlev Hospital 10
Early research (Phase 1)Study completedNCT00468091
What this trial is testing

Effects of Exendin(9-39) on Gastroduodenal Motility

Who this might be right for
Digestive PhysiologyGastrointestinal MotilityGastrointestinal Hormones+2 more
Ludwig-Maximilians - University of Munich 10
Post-approval studies (Phase 4)UnknownNCT05606471
What this trial is testing

Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets

Who this might be right for
Type 2 Diabetes Mellitus in Obese
University of Nottingham 45
Post-approval studies (Phase 4)Not Yet RecruitingNCT07073053
What this trial is testing

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Who this might be right for
Glucagon-Like Peptide-1 Receptor AgonistsType 2 DiabetesCoronary Arterial Disease (CAD)
Taipei Veterans General Hospital, Taiwan 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07213466
What this trial is testing

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Who this might be right for
Bipolar I DisorderBipolar II DisorderSchizo Affective Disorder+3 more
Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT01452451
What this trial is testing

Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Hanmi Pharmaceutical Company Limited 72
Large-scale testing (Phase 3)Temporarily pausedNCT03508739
What this trial is testing

Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Who this might be right for
Diabetes Mellitus, Type 2Pre-diabeticHypertension+1 more
University of Pennsylvania 25
Post-approval studies (Phase 4)Not Yet RecruitingNCT07111494
What this trial is testing

Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial

Who this might be right for
Psoriatic Arthritis (PsA)
Medical College of Wisconsin 22
Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing

Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254
Early research (Phase 1)Study completedNCT00882492
What this trial is testing

GLP 1 for Intraoperative Glycemic Control

Who this might be right for
HyperglycemiaHypoglycemia
University of Pennsylvania 80
Not applicableStudy completedNCT04610203
What this trial is testing

Glycaemic Response, Insulinaemic Response, GLP-1 and GIP Testing of Food Product Lines

Who this might be right for
Healthy
Oxford Brookes University 41
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Not applicableStudy completedNCT03085511
What this trial is testing

High Quality Protein for Assisting With Weight Loss

Who this might be right for
Obesity
Texas Tech University 40
Not applicableStudy completedNCT03246451
What this trial is testing

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

Who this might be right for
Glucose Metabolism Disorders
University Hospital, Gentofte, Copenhagen 15
Testing effectiveness (Phase 2)Study completedNCT07370922
What this trial is testing

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Who this might be right for
Transfusion Dependent Beta Thalassemia
Ain Shams University 80
Early research (Phase 1)Study completedNCT07294898
What this trial is testing

Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight

Who this might be right for
ObesityOverweight
Kailera 18
Load More Results